Lessons from patient-derived xenografts for... : Advanced Drug Delivery Reviews (original) (raw)

Lessons from patient-derived xenografts for better in vitro modeling of human cancer☆,☆☆

Advanced Drug Delivery Reviews

79-80

:p

222

-

237

,

December 2014

.

| DOI: 10.1016/j.addr.2014.09.009

The development of novel cancer therapeutics is often plagued by discrepancies between drug efficacies obtained in preclinical studies and outcomes of clinical trials. The inconsistencies can be attributed to a lack of clinical relevance of the cancer models used for drug testing. While commonly used in vitro culture systems are advantageous for addressing specific experimental questions, they are often gross, fidelity-lacking simplifications that largely ignore the heterogeneity of cancers as well as the complexity of the tumor microenvironment. Factors such as tumor architecture, interactions among cancer cells and between cancer and stromal cells, and an acidic tumor microenvironment are critical characteristics observed in patient-derived cancer xenograft models and in the clinic. By mimicking these crucial in vivo characteristics through use of 3D cultures, co-culture systems and acidic culture conditions, an in vitro cancer model/microenvironment that is more physiologically relevant may be engineered to produce results more readily applicable to the clinic.

Graphical abstract

Copyright © 2014Elsevier, Inc.